The Trevo Retriever is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Introduction
Flow diversion is a treatment approach that aims to exclude the aneurysm from the blood circulation by reconstruction of the parent vessel. Proper flow diverter (FD) wall apposition is essential in order to modify the aneurysm inflow pattern adequately, which in the long term can lead to stable intra-saccular thrombus formation.
Technical complications associated with the Pipeline embolization device (PED; Medtronic Neurovascular, Irvine, CA) such as FD malapposition and proximal migration may pose risks for delayed ischemic events or potentially delayed life-threatening aneurysm rupture. 1, 2 Despite our knowledge of potential complications and the need for evaluation of stent wall apposition, the interventionalist still faces a challenge during cases in which simple techniques such as running the microwire/microcatheter, balloon angioplasty, or advancing the intermediate catheter into the FD do not treat device malapposition. Although these techniques are often successful for braided FDs, malapposition occurring at the end of the device in a curve can be difficult to correct without placement of additional PEDs.
We present our experience with the use of a selfexpanding intracranial stent as an adjunctive management option in cases of inadequate vessel-wall apposition after FD implantation, along with our approach for assessment of proper FD wall apposition.
Methods
This retrospective study was approved by the hospital Institutional Review Board, and written informed patient consent was obtained.
Patients
We performed 40 FD procedures between May and July 2015. We included all patients who were treated with the PED in conjunction with a self-expanding Neuroform EZ stent (Stryker Neurovascular, Fremont, CA). For each patient, vascular risk factors and aneurysm characteristics were identified. Relevant clinical data, including symptoms at presentation, neurological examination at baseline and outcome based on National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) scores at discharge, were recorded. mRS at follow-up was documented. Pre-and post-treatment imaging was evaluated for the occurrence of thromboembolic events, vessel patency, and alternation of intra-saccular flow dynamics (Table 1) .
Diagnostic procedure and interventional approach
All patients underwent computed tomography (CT) scanning of the head and received digital subtraction angiography (DSA) prior to intervention. All aneurysms were located in the anterior circulation. One patient had two small aneurysms at the left ophthalmic and superior hypophyseal artery. Both aneurysms were covered by a single PED device.
Patients were given 81 mg of aspirin and 75 mg of clopidogrel daily for at least five days prior to the elective procedure. Patients were tested prior to the procedure to ensure therapeutic antiplatelet effect, defined in our practice by P2Y12 assay (VerifyNow, Accumetrics, San Diego, CA) showing at least 50% platelet inhibition or PRU of <200 with platelet aggregation assay. Per our protocol, dual antiplatelet therapy is continued for a minimum of six months, with aspirin continued throughout life.
Diagnostic and interventional procedures were performed on a biplane digital angiography system (Allura Biplane FD20/20; Philips Healthcare, Best, Netherlands). All patients underwent treatment under general anesthesia.
A triaxial system was used consisting of an 8 F long sheath, 6 F Shuttle guide catheter, and an intermediate guide catheter, which was placed into the petrous/cavernous segment of the carotid artery. Prior to placement of the intermediate catheter, a vasodilator was slowly infused to prevent any catheter-related spasm. Apart from the standard projections and the three-dimensional (3D) angiography, magnified views were obtained to visualize the full length of the FD properly, with special focus on the distal and proximal aspect of the device. The PED was deployed via either an XT27 microcatheter (Stryker Neurovascular) or Marksman microcatheter (Medtronic Neurovascular). The PED was sized according to the larger diameter of the intended vessel to prevent any endoleak. There was no unusual size discrepancy in the diameters of the distal and proximal indented landing zones. The deployment of the PED was as per IFU with a combination of unsheathing and pushing out of the device for better wall apposition.
After deployment of the FD, a 30% dilute contrastenhanced high-resolution cone-beam CT (VasoCT) and Xper-CT (Philips, Best, The Netherlands) was performed to assess PED wall apposition 3 and to evaluate for intracranial hemorrhage.
A self-expandable Neuroform EZ stent (Stryker Neurovascular) was placed in 3/5 cases in order to correct the inadequate vessel-wall apposition permanently. In the other two cases, we observed proximal migration of the distal aspect of the FD after successful deployment of the device due to inadequate wall apposition. The stent was placed in a telescopic fashion either overlapping the distal or proximal portion of the PED. Balloon angioplasty prior to stent placement was performed in 3/5 cases in an effort to correct the incomplete apposition of the FD with the parent artery wall.
Follow-up angiography and 3D multiplanar conebeam CT reconstruction images for confirmation of adequate placement of the Neuroform EZ stent and good vessel-wall apposition of both devices was performed in all cases prior to completion of the procedure.
Short-term follow-up angiography
Follow-up angiography was scheduled for 6, 12, and 18 months. Imaging was evaluated for vessel patency, aneurysm obliteration and the development of intimal hyperplasia. Cone-beam CT was also performed to confirm stable wall apposition of the Pipeline device and Neuroform EZ stent.
Results

Baseline characteristics
We identified five patients (three females) with a mean age of 53 years (range 35-71 years). Patient vascular risk factors included smoking (3/5), dyslipidemia (1/5), and hypertension (2/5). One patient presented with blurred vision and another with recanalization of a previously clipped, ruptured aneurysm. On admission, NIHSS and mRS were 0 in all cases ( Table 1) . Endovascular interventions were performed by two interventional neuroradiologists with experience of 300-500 placed FDs. Proximal migration of the PED was seen in two cases after PED deployment/balloon angioplasty and was attributed to challenging vascular anatomy. In both of these cases, the aneurysm neck remained completely covered by the PED. It was, however, felt necessary to anchor the PED adequately against the vessel wall due to the risk of further proximal migration over time leading to uncovering of the aneurysm. Incomplete vessel-wall apposition of either the proximal or distal edge of the device was seen in the three remaining cases. All patients were treated with a single PED and Neuroform stent. No associated coiling was performed. Adequate vessel-wall apposition and complete aneurysm neck coverage was achieved in all cases.
Clot formation after placement of the Neuroform stent was observed in one patient, which was immediately and successfully treated with the administration of a glycoprotein IIb/IIIa inhibitor.
All patients tolerated the procedure well. The postprocedural NIHSS and mRS scores at discharge remained 0 for all patients.
Follow-up evaluation
Short-term follow-up was available for all patients. One patient had a six-month and one-year follow-up that showed a patent PED and Neuroform stent with complete aneurysm occlusion and no intimal hyperplasia. Another patient (#5) had a one-year and 18-month follow-up that also showed complete occlusion and no intimal hyperplasia. Due to stable findings at 18 months, these results were not included in the table.
Three patients had six-month follow-ups only. Two showed complete aneurysm obliteration and stent patency without intimal hyperplasia. The third patient showed complete occlusion of the left superior hypophyseal and near complete occlusion of the left ophthalmic aneurysm. The PED and Neuroform remained patent. Neurologic evaluation at the time of follow-up remained unchanged. (Figure 1(a) ). After appropriate positioning of the microcatheter, a 3.75 mm Â 18 mm PED was placed over the aneurysm neck. Follow-up magnified oblique views showed flow stagnation within the right cavernous ICA aneurysm (Figure 1(b) , arrow head). However, there was malapposition at the distal aspect of the FD (Figure 1(b) , block arrow). Balloon angioplasty was performed using a TransForm 4 mm Â 10 mm compliant balloon (Stryker Neurovascular; Figure 1(c) ). Persistent malapposition of the distal aspect of the PED was seen on subsequent angiography images (Figure 1(d) , arrow). A 4.5 mm Â 20 mm Neuroform EZ stent was then deployed in telescoping fashion, partially within the previously placed PED (Figure 1(e) , arrows). The stent covered the aneurysm neck and extended beyond the distal end of the PED, resulting in appropriate vessel-wall apposition of the distal portion of the FD. Six-month follow-up angiography showed a patent PED with overlapping Neuroform stent in the distal petrous and cavernous portion of the right ICA without evidence of stenosis or significant intimal hyperplasia. There was complete obliteration of the aneurysm (Figure 1(f) ). One-year follow-up angiography demonstrated a patent ICA without evidence of aneurysm recurrence (Figure 1(g) ). Cone-beam CT with multiplanar 3D-reconstructions (Philips Healthcare) confirmed proper PED wall apposition (Figure 1(h) ).
Case 2. Selective catheter angiography of the right ICA revealed a saccular 3 mm Â 2 mm Â 3 mm aneurysm of the right M2 segment (inferior division; Figure 2 (a), arrow head) as well as a 2 mm Â 3 mm Â 1 mm fusiform aneurysm mostly involving the right superior M2 division (Figure 2(a) , arrow). A proximal stenosis of the M2 origin was also noted. Cone-beam CT with 3D reconstruction images (Philips Healthcare) was acquired for procedure planning and better visualization of the vessel anatomy (Figure 2(b) ). After successful balloon-assisted coil embolization of the saccular aneurysm and angiographic confirmation of aneurysm occlusion, the catheters were exchanged. A Marksman microcatheter (Medtronic Neurovascular) was then positioned in the anterior division of the right MCA and ultimately across the aneurysm into the artery of Rolando (M3 division). A 3.0 mm Â 15 mm PED (FLEX) was navigated through the microcatheter into the M3 segment and gently deployed across the fusiform aneurysm and covering the posterior M2 division. This represents an off-label use of the FD.
After removal of the PED delivery system, there was foreshortening of the distal portion of the PED, which migrated proximally up to the level of the aneurysm segment (Figure 2 (c) and (d) arrow). To avoid a further proximal migration, an Excelsior XT 27 microcatheter (Stryker Neurovascular) was navigated through the PED into the M3 segment. In a telescoping fashion, a 3.0 mm Â 15 mm Neuroform EZ stent was navigated across the PED and placed covering the distal part of the PED and anchoring it safely across the aneurysm neck. Three-dimensional reconstruction images showed excellent wall apposition of both devices and appropriate jailing of the distal edge of the FD by the overlapping Neuroform (Figure 2 (e) and arrow in Figure 2(f) ). Six-month follow-up angiogram showed perfect apposition of the FD and the overlapping Neuroform stent, with complete occlusion of the fusiform aneurysm ( Figure 2 (g), arrows on distal and proximal end of Neuroform stent; arrow heads at distal and proximal edges of the PED). The previously noted stenotic segment at the proximal M2 segment was unchanged. The coiled aneurysm remained occluded. Three-dimensional reconstruction images confirmed proper jailing of the distal edge of the PED by the overlapping Neuroform stent (Figure 2(h) , arrow). Case 3. This patient was status post clipping of a previously ruptured right MCA aneurysm. Digital subtraction angiography of the right ICA revealed a wide-neck right MCA bifurcation aneurysm measuring approximately 4 mm Â 3 mm Â 3 mm and involving both MCA divisions (Figure 3(a) , arrow). A cone-beam CT with multiplanar 3D reconstruction images was obtained for procedure planning and re-demonstrates the MCA aneurysm with better delineation of the vessel anatomy (Figure 3(b) ). After appropriate positioning of the Navien guide catheter and Marksman microcatheter using triaxial technique, real-time fluoroscopy, and biplane roadmapping, a 2.75 mm Â 16 mm (FLEX) PED was placed over the neck of the right MCA bifurcation aneurysm (Figure 3(c) , arrows on proximal and distal tip of the device). This represents an off-label use of the FD.
After complete deployment of the PED, proximal migration of the FD was observed. Despite this, the aneurysm neck remains completely covered. To avoid further PED migration, a 3.0 mm Â 15 mm Neuroform EZ stent was placed distal to the aneurysm into the MCA-M2 division and proximal pinning the PED into the M1 segment in telescoping fashion (Figure 3(d) , arrows on proximal and distal tip of the PED; arrow heads on proximal and distal tip of the Neuroform stent). All angiographically visible perforating branches as well as the covered anterior M2 division were patent (Figure 3(e) ). Three-dimensional reconstruction images demonstrated the distal aspect of the PED just distal to the aneurysm neck (Figure 3(f) , arrow) and showed appropriate jailing of the distal edge of the FD by the overlapping Neuroform stent (Figure 3(g) , arrows on proximal and distal tip of the PED; arrow heads on proximal and distal tip of the Neuroform stent). Six-month follow-up angiography showed complete occlusion of the aneurysm without evidence of in-stent stenosis (Figure 3(h) ). Reconstruction images confirmed stable position of the stent and FD with proper vessel-wall apposition (Figure 3(i) ).
Discussion
FD malapposition is associated with an increased risk of stroke-related complications. 1, 4 In 2013, Heller et al. 5 found that incomplete stent apposition after stentassisted coiling of intracranial aneurysms was associated with a higher risk of periprocedural thromboembolic and delayed ischemic events. Incomplete vessel-wall apposition of FDs may also impede its ability to redirect blood flow away from the aneurysm sac, which then could interfere with stable intra-aneurysmal thrombus formation and flow stagnation. Lubizc et al. 2 reported an increased risk of delayed aneurysm rupture after treatment with the PED; this is attributed to proximal migration of the device and redirection of flow into the aneurysm sac.
More recent reports have described delayed complications associated with proximal migration of the FD. [6] [7] [8] [9] We saw immediate proximal migration of the distal end of the PED after placement in the two patients with MCA aneurysms, which was likely due to the inadequate wall apposition and challenging vascular anatomy. These patients are at risk of uncovering of the aneurysm lumen and even further migration of the PED during the healing process. We were able to anchor the PED to the vessel wall successfully using a self-expanding Neuroform EZ stent. As we have seen several cases with initially a proper coverage of the aneurysm neck with a PED and in a delayed fashion migration of the FD into the aneurysm on follow-up angiograms, we propose a preventive treatment if the FD is covering only the margins of the aneurysm neck by a few millimeters. Placement of a non-retrievable stent such as a NF in a telescoping fashion through a FD is easily accomplished. Since its radial force is significantly higher, pinning the FD by overlapping the ends of the FD by only a few millimeters is sufficient, thereby avoiding further migration or movement of the FD.
Placement of a second FD in such cases is definitely an option. However, this may not always be possible, especially in a perforator-rich zone where the increased metal-to-artery ratio may lead to perforator occlusion. Also, placing another FD may be a relatively costly alternative.
Malapposition of the edges of the PED was seen in the remaining three patients. Given the uncertainty of potential complications with inadequate wall apposition, we elected to address the situation with the use of self-expanding stents. Off-label use of FDs has to be carefully considered, and the risks, benefits, and potential complication have to be weighed against conventional endovascular aneurysm treatment or possible conservative therapy options.
Cone-beam CT is an accepted method for evaluation of FD stent apposition. 10 It allows for exact visualization of stent position, orientation, aneurysm neck coverage, and degree of malapposition. 4 All our patients routinely undergo cone-beam CT evaluation after device placement. The current literature reports potentially devastating results as a consequence of stent malapposition and provides information on how to detect incomplete vessel-wall apposition after stent placement reliably, but there are no guidelines on how to manage cases in which FD malapposition is refractory to angioplasty or in cases which device migration compromises the optimal aneurysm neck coverage.
In our case series, we successfully treated five patients with FDs in combination with self-expanding intracranial stents to address inadequate FD wall apposition.
The proposed use of a Neuroform stent is for two situations: (1) the aneurysm has been covered by the FD, but a risk of migration is imminent or the coverage is marginal so a pinning of the FD by a higher radial force stent is desirable, and (2) the wall apposition of the FD around artery bents is inadequate and cannot be resolved by post dilatation with a balloon.
The two most favorable physical properties of the Neuroform EZ stent are its high outward radial force and open-cell design. Laser-cut tubes/stents with a closed-cell design such as the Neuroform have a three to five times higher radial force than braided devices/ stents/FDs, especially when the FD is placed in smaller vessel diameters than the nominal diameter of the device. In braided stents/FD, the radial force is maximal in the center under nominal diameter, that is, the FD is not under constraint. The radial force drops rapidly toward both ends of the FD. If a FD is under constraint, that is, placed in an artery with a vessel diameter smaller than the nominal diameter of the FD, the radial force drops dramatically. This can easily be tested by calculating the crush test (force applied to compress the FD) with various device diameters. The combination of both high radial force and open-cell design allows the stent to jail the edge of the unopposed FD against the vessel wall and maintain adequate wall apposition itself at the same time. Rahal et al. 7 have previously described successful use of Solitaire stents (high radial force) in the cervical ICA in an effort to anchor the FD adequately to the vessel wall.
Our case series is mainly limited by its retrospective nature and small patient number.
Conclusion
The preliminary results of our small case series suggest that management of inadequate FD position may safely be performed by use of a self-expanding Neuroform EZ stent. Currently, no clear guidelines for the management of inadequate FD wall apposition exist. In such cases, the physical properties of the self-expanding Neuroform EZ stent provide an effective adjunctive treatment in selected patients amenable for this endovascular approach. Long-term and larger cohort studies are needed to evaluate this approach further and to validate its long-term potential.
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